- Case report
- Open Access
Acute cytomegalovirus infection complicated by venous thrombosis: a case report
Annals of Clinical Microbiology and Antimicrobialsvolume 4, Article number: 11 (2005)
CMV-induced vasculopathy and thrombosis have been reported, but they are rare conditions usually encountered in immunocompromised patients. However more and more complications of CMV infections are recognized in immunocompetent patients.
We present a case report of a previously healthy adult with cytomegalovirus infection that was complicated by tibiopopliteal deep venous thrombosis and in whom Factor V Leiden heterozygous mutation was found.
This new case report emphasizes the involvement of cytomegalovirus in induction of vascular thrombosis in patients with predisposing risk factors for thrombosis. It is necessary to screen for CMV infection in patients with spontaneous thrombosis and an history of fever.
CMV-induced vasculopathy and thrombosis have been reported, but they are rare conditions. The few published reports on these conditions focus either on immunocompromised transplant recipients who are receiving high-dose immunosuppressive agents [1, 2] or on HIV-infected patients [3–5]. We report one new case of acute CMV infection in a non-immunocompromised adult that presented as spontaneous venous thrombosis. There are few reports involving immunocompetent adults, and these reports are additional arguments for the implication of CMV in vasculopathy and thrombosis.
A 33-year-old white man with a 5-day history of fever, was hospitalized on May 2004. He also reported epigastralgia and pain in the right leg. He had an history of femoral deep venous thrombosis ten years before. His mother and his brother had an history of deep venous thrombosis and his father died because of pulmonary embolism. Physical examination revealed fever (temperature range 38°C–38°5C), asthenia, headache, anorexia and epigastralgia. His right leg was enlarged and painful. Tibiopopliteal deep venous thrombosis was confirmed by Doppler ultrasonography. At the time of hospital admission, his WBC was 6,000 cells/mm3, with 2,100 neutrophils/mm3 and 2,820 lymphocytes/mm3, with 9% of hyperbasophilic lymphocytes. His platelet count was 120,000/mm3 and his hemoglobin level was 141 g/l. The C-reactive protein level was 52 mg/l. Liver function tests revealed an ALT level of 65 UI/l, an AST level of 64 UI/l, an LDH level of 891 UI/l, a PAL level of 61 UI/l and a γ-GT level of 41 UI/l. Blood cultures were sterile. The results of serological tests for HIV ELISA, hepatitis A IgM, hepatitis B surface antigen, hepatitis C virus, Q fever, and toxoplasma were negative. VCA and EBNA IgG antibodies were positive suggesting past immunization. Serological test for CMV ELISA was strongly positive for IgM antibodies. The result of a CMV pp65 antigenemia assay, based on the direct detection of the CMV pp65 phosphoprotein was positive. A second serological test for CMV taken two weeks after the first one showed seroconversion with appearance of IgG. No pathological values for prothrombin time ratio, activated partial thromboplastin time, plasma antithrombin III, protein C and S activity were found. Results of tests for anticardiolipin antibodies, lupus anticoagulant and prothrombin 20210 were negative. Antinuclear antibodies were negative and complement was normal. Factor V Leiden heterozygous mutation was found. Anticoagulant treatment was introduced. Tthe patient became asymptomatic and was discharged from the hospital.
Our observation, as well those of others [6, 7], argues for implication of CMV in vasculopathy and thrombosis. In these cases, thrombosis occurred in immunocompetent patients during CMV infection, which was confirmed, in most cases, by pp65 antigen and/or CMV viremia/viruria. There are few reports involving immunocompetent adults since we retrieved only 13 reports through MEDLINE database [6–16]. Predisposing risk factors for thrombosis have sometimes been found in the reported cases such as protein C and S deficiency  and the presence of antiphospholipid antibodies [10, 13, 16, 17]. In other reports, patients were women and had risk factors such as oral contraceptive use [8, 9, 14]. The factor V Leiden heterozygous mutation was only reported once previously . However in some other reported cases, no hemostatic abnormalities can be found [6, 7, 17] and spontaneous resolutions of thrombosis were observed in some of these patients who did not receive anticoagulant treatment . This suggests that CMV was the sole triggering factor. These observations suggest that acute CMV infection may be the cause of the thrombosis event in these patients. However, it is difficult to determine whether CMV is a direct cause of thrombosis or a precipitating factor in patients with underlying thrombogenic tendency. Considering that CMV could be a transient triggering factor for thrombosis in our patient, we decided not to treat lifelong as recommended for patients with factor V Leiden heterozygous mutation and 2 spontaneous thrombosis  but only for 6 months .
In conclusion, our case report reinforces the opinion that CMV is a rare but potentially signifiant cause or precipitating factor of arterial and venous thrombosis in immunocompetent hosts . It seems to be necessary to screen for CMV infection in patients with spontaneous thrombosis and an history of fever. It is important to recognize CMV infection in these patient as it may be possible to consider the discontinuation of anticoagulant therapy earlier.
Koskinen PK, Nieminen MS, Krogerus LA, Lemstrom KB, Mattila SP, Hayry PJ, Lautenschlager IT: Cytomegalovirus infection and accelerated cardiac allograft vasculopathy in human cardiac allografts. J Heart Lung Transplant. 1993, 12: 724-29.
Madalasso C, de Souza NFJ, Ilstrup DM, Wiesner RH, Rom RA: Cytomegalovirus and its association with hepatic artery thrombosis after liver transplantation. Transplantation. 1998, 66: 294-97. 10.1097/00007890-199808150-00003
Bayer DD, Sorbello AF, Condolucci DV: Bilateral subclavian vein thrombosis in a patient with acquired immunodeficiency syndrome. J Am Osteopath Assoc. 1995, 95: 276-77.
Jenkins PE, Peters BS, Pinching AJ: Thromboembolic disease in AIDS is associated with cytomegalvirus disease. AIDS. 1991, 5: 1540-1542.
Sullivan PS, Dworkin MS, Jones JL, Hooper WC: Epidemiology of thrombosis in HIV-infected individuals. AIDS. 2000, 5: 1540-1542.
Abgueguen P, Delbos V, Chennebault JM, Payan C, Pichard E: Vascular thrombosis and acute cytomegalovirus infection in immunocompetent patients: report of 2 cases and literature review. Clin Infect Dis. 2003, 36: 134-38. 10.1086/374664.
Ofotokun I, Carlson C, Gitlin SD, Elta G, Singleton TP, Markovitz DM: Acute cytomegalovirus infection complicated by vascular thrombosis: a case report. Clin Infect Dis. 2001, 32: 983-86. 10.1086/319353
Inacio C, Hillaire S, Valla D, Denninger MH, Casadevall N, Erlinger S: Case report: cytomegalovirus infection as a cause of acute portal vein thrombosis. J Gastroenterol Hepatol. 1997, 12: 287-88.
De Celis G, Mir J, Casal J, Gomez D: 31-year-old woman with an enlarged tender liver. Lancet. 1995, 346: 1270- 10.1016/S0140-6736(95)91867-1
Uthman I, Tabbarah Z, Gharavi AE: Hughes syndrome associated with cytomegalovirus infection. Lupus. 1999, 8: 775-77. 10.1191/096120399678841034
Ailani RK, Simms R, Caracioni AA, West WC: Extensive mesenteric inflammatory veno-occlusive disease of unknown etiology after primary cytomegalovirus infection: first case. Am J Gastroenterol. 1997, 92: 1216-18.
Lanari M, Lazzarotto T, Papa I, Venturi V, Bronzetti G, Guerra B, Faldella G, Corvaglia L, Picchio FM, Landini MP, Salvioli GP: Neonatal aortic arch thrombosis as a result of congenital cytomegalovirus infection. Pediatrics. 2001, 108: E114- 10.1542/peds.108.6.e114
Labarca JA, Rabaggliati RM, Radrigan FJ, Rojas PP, Perez CM, Ferres MV, Acuna GG, Bertin PA: Antiphospholipid syndrome associated with cytomegalovirus infection: case report and review. Clin Infect Dis. 1997, 24: 197-200.
Estival JL, Debourdeau P, Zammit C, Teixeira L, Guerard S, Colle B: Thrombose porte spontanée associée à une infection aiguë à cytomégalovirus chez une patiente immunocompétente. Presse Med. 2001, 30: 1876-1878.
Arav-Boger R, Reif S, Bujanover Y: Portal vein thrombosis caused by protein C and protein S deficiency associated with cytomegalovirus infection. J Pediatr. 1995, 126: 586-588.
Youd P, Main J, Jackson E: Cytomegalovirus infection and thrombosis: a causative association. J Infect. 2003, 46: 141-143. 10.1053/jinf.2002.1035
Benoist S, Laisné MJ, Joly F, Boudiaf M, Panis Y, Valleur P: Cytomegalovirus infection as a cause of acute superior mesenteric vein thrombosis with jejunal infarction. Surgery. 2003, 133: 222-223. 10.1067/msy.2003.8
Bauer KA: The thrombophilias: well-defined risk factors with uncertain therapeutic implications. Ann Intern Med. 2001, 135: 367-373.
Auerbach AD, Sanders GD, Hambleton J: Cost-effectiveness of testing for hypercoagulability and effects on treatment strategies in patients with deep vein thrombosis. Am J Med. 2004, 116: 816-828. 10.1016/j.amjmed.2004.01.017
Squizzato A, Gerdes VEA, Büller HR: Effects of human cytomegalovirus infection on the coagulation system. Thromb Haemost. 2005, 93: 403-410.
We thank Ann Kasmar for reviewing the manuscript